View in EDS PDF Full Text

AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression.

Saved in:
Bibliographic Details
Title: AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression.
Authors: Miller J; Department of Pathology, Center for Cell Reprogramming, Georgetown University Medical School, Washington, District of Columbia, USA., Dakic A; Department of Pathology, Center for Cell Reprogramming, Georgetown University Medical School, Washington, District of Columbia, USA., Spurgeon M; McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA., Saenz F; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical School, Washington, District of Columbia, USA., Kallakury B; Department of Pathology, Center for Cell Reprogramming, Georgetown University Medical School, Washington, District of Columbia, USA., Zhao B; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Zhang J; Department of Radiation Oncology, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA.; The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA., Zhu J; Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA., Ma Q; The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.; Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, Ohio, USA., Xu Y; Computational Systems Biology Lab, Department of Biochemistry and Molecular Biology and Institute of Bioinformatics, The University of Georgia, Athens, Georgia, USA., Lambert P; McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA., Schlegel R; Department of Pathology, Center for Cell Reprogramming, Georgetown University Medical School, Washington, District of Columbia, USA., Riegel AT; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical School, Washington, District of Columbia, USA., Liu X; Department of Pathology, Center for Cell Reprogramming, Georgetown University Medical School, Washington, District of Columbia, USA.; The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.; Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA.
Source: Journal of medical virology [J Med Virol] 2022 Aug; Vol. 94 (8), pp. 3962-3977. Date of Electronic Publication: 2022 Apr 27.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9071 (Electronic) Linking ISSN: 01466615 NLM ISO Abbreviation: J Med Virol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35437795
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Miller+J%22">Miller J</searchLink>; Department of Pathology, Center for Cell Reprogramming, Georgetown University Medical School, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Dakic+A%22">Dakic A</searchLink>; Department of Pathology, Center for Cell Reprogramming, Georgetown University Medical School, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Spurgeon+M%22">Spurgeon M</searchLink>; McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Saenz+F%22">Saenz F</searchLink>; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical School, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Kallakury+B%22">Kallakury B</searchLink>; Department of Pathology, Center for Cell Reprogramming, Georgetown University Medical School, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Zhao+B%22">Zhao B</searchLink>; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Department of Radiation Oncology, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA.; The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+J%22">Zhu J</searchLink>; Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Ma+Q%22">Ma Q</searchLink>; The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.; Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Computational Systems Biology Lab, Department of Biochemistry and Molecular Biology and Institute of Bioinformatics, The University of Georgia, Athens, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Lambert+P%22">Lambert P</searchLink>; McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Schlegel+R%22">Schlegel R</searchLink>; Department of Pathology, Center for Cell Reprogramming, Georgetown University Medical School, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Riegel+AT%22">Riegel AT</searchLink>; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical School, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; Department of Pathology, Center for Cell Reprogramming, Georgetown University Medical School, Washington, District of Columbia, USA.; The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.; Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227705876%22">Journal of medical virology</searchLink> [J Med Virol] 2022 Aug; Vol. 94 (8), pp. 3962-3977. <i>Date of Electronic Publication: </i>2022 Apr 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7705876 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-9071 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201466615%22">01466615 </searchLink><i>NLM ISO Abbreviation: </i>J Med Virol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35437795
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/jmv.27795
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3962
    Titles:
      – TitleFull: AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Miller J
      – PersonEntity:
          Name:
            NameFull: Dakic A
      – PersonEntity:
          Name:
            NameFull: Spurgeon M
      – PersonEntity:
          Name:
            NameFull: Saenz F
      – PersonEntity:
          Name:
            NameFull: Kallakury B
      – PersonEntity:
          Name:
            NameFull: Zhao B
      – PersonEntity:
          Name:
            NameFull: Zhang J
      – PersonEntity:
          Name:
            NameFull: Zhu J
      – PersonEntity:
          Name:
            NameFull: Ma Q
      – PersonEntity:
          Name:
            NameFull: Xu Y
      – PersonEntity:
          Name:
            NameFull: Lambert P
      – PersonEntity:
          Name:
            NameFull: Schlegel R
      – PersonEntity:
          Name:
            NameFull: Riegel AT
      – PersonEntity:
          Name:
            NameFull: Liu X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1096-9071
          Numbering:
            – Type: volume
              Value: 94
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Journal of medical virology
              Type: main
ResultId 1